FGF19 and FGF21 are also considered as predictors of development of some diseases, for example, type 2 diabetes, non-alkoholic fatty liver disease, atherosclerosis, coronary artery disease, and chronic kidney disease. This evidence concerns the gene FGF19 and coronary artery disorder.